Phase 3, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment for patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Bang, Y-J, Ruiz, E Yañez, Van Cutsem, E, Lee, K-W, Wyrwicz, L, Schenker, M, Alsina, M, Ryu, M-H, Chung, H-C, Evesque, L, Al-Batran, S-E, Park, S H, Lichinitser, M, Boku, N, Moehler, M H, Hong, J, XionLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy264
Date:
July, 2018
File:
PDF, 780 KB
english, 2018
File converter
More search results
More benefits 
